H.R. 7407House119th Congress (2025-2027)In Committee

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

AI-Generated Summary

Updated February 20, 2026 at 11:22 AM UTC

The Prohibiting Tianeptine and Other Dangerous Products Act of 2026 amends the Federal Food, Drug, and Cosmetic Act to create two new illegal actions for dietary supplements. It bars the sale or distribution of supplements that don’t meet the official definition of a supplement, and it also bars supplements that are handled by anyone who has been debarred from FDA‑regulated activities. The changes give the FDA new powers to block imports and seize such products, affecting supplement manufacturers, distributors, importers, and debarred individuals.

Key Provisions

Adds a new prohibited act (jjj) that makes it illegal to introduce or deliver into interstate commerce any product marketed as a dietary supplement if it does not meet the legal definition of a dietary supplement under the FD&C Act.
Adds a new prohibited act (kkk) that makes it illegal to introduce or deliver into interstate commerce a dietary supplement that was prepared, packed, or stored with the help of, or under the direction of, a person who has been debarred from participating in FDA-regulated activities.
Amends the import rules so that products violating the new (jjj) or (kkk) provisions can be excluded from entry into the United States.
Expands FDA seizure authority to allow the agency to seize and condemn products that violate the new (jjj) or (kkk) prohibited acts.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action

HouseIntro Referral Latest Action

Referred to the House Committee on Energy and Commerce.

Energy and Commerce Committee

February 5, 2026

View full timeline

HouseIntro Referral

Introduced in House

February 5, 2026

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

Energy and Commerce Committee

February 5, 2026

Bill Text

Latest available legislative text

Reading Mode

Raw Text PDF XML

Introduced in HouseIssued February 5, 2026

119th CONGRESS

2d Session

H. R. 7407

IN THE HOUSE OF REPRESENTATIVES

February 5, 2026

Mr. Pallone introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.

Short title

This Act may be cited as the Prohibiting Tianeptine and Other Dangerous Products Act of 2026.

New prohibited acts relating to dietary supplements

(a)

In general

Section 301 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331) is amended by adding at the end the following:

(jjj)

The introduction or delivery for introduction into interstate commerce of any product marketed as a dietary supplement that does not meet the definition of a dietary supplement under section 201(ff).

(kkk)

The introduction or delivery for introduction into interstate commerce of a dietary supplement that has been prepared, packed, or held using the assistance of, or at the direction of, a person debarred under section 306.

(b)

New import exclusion

Section 801(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(a)) is amended in paragraph (3) of the third sentence, by striking section 301(ll) and inserting paragraph (ll), (jjj), or (kkk) of section 301.

(c)

New seizure authorities

Section 304 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 334) is amended—

(1)

in subsection (a)(1), in the first sentence, by striking section section 301(ll), 404, or 505 and inserting paragraph (ll), (jjj), or (kkk) of section 301, section 404, or section 505; and

(2)

in subsection (d)(1), in the first sentence, by inserting , or product in violation of paragraph (jjj) or (kkk) of section 301, after condemned under this section.